Associated thromboembolic events to the post COVID syndrome: a systematic review and meta-analysis - Top-Institutions - MDSpire

Associated thromboembolic events to the post COVID syndrome: a systematic review and meta-analysis

  • By

  • Jesús Endara-Mina

  • Cristopher-Josue Escudero

  • Cesar Intriago

  • Lisseth Coloma-Ramirez

  • Wilson Cabrera

  • Rosa Gonzaga

  • Sebastian Fuentes

  • Dario Chicaiza

  • Carlos Carvajal

  • Rafael Lopez-Carrera

  • Belen Baño-Jimenez

  • Jordy Ruilova

  • Erick Atahualpa

  • Josue Aldaz

  • Mayuri Quishpe

  • Katherine Simbaña-Rivera

  • June 11, 2026

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Hôpitaux Universitaires de Strasbourg
    Hôpitaux Universitaires de Strasbourg

    Strasbourg, Grand Est

    Key Differentiators

    • Hematology

  • #2

    Centre Hospitalier Universitaire de Besancon
    Centre Hospitalier Universitaire de Besancon

    Besançon, Bourgogne-Franche-Comté

    Key Differentiators

    • Hematology

  • #3

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, Massachusetts

    Key Differentiators

    • Hematology
    • Pulmonary Medicine

  • #4

    Brigham and Women’s Hospital
    Brigham and Women’s Hospital

    Boston, Massachusetts

    Key Differentiators

    • Hematology
    • Pulmonary Medicine

Original Source(s)

Associated thromboembolic events to the post COVID syndrome: a systematic review and meta-analysis

  • by Jesús Endara-Mina, Cristopher-Josue Escudero, Cesar Intriago, Lisseth Coloma-Ramirez, Wilson Cabrera, Rosa Gonzaga, Sebastian Fuentes, Dario Chicaiza, Carlos Carvajal, Rafael Lopez-Carrera, Belen Baño-Jimenez, Jordy Ruilova, Erick Atahualpa, Josue Aldaz, Mayuri Quishpe, Katherine Simbaña-Rivera

  • June 11, 2026

Related Content

One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients

Impact of COVID-19 on outcomes with teclistamab in patients with relapsed/refractory multiple myeloma in the phase 1/2 MajesTEC-1 study

Immune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19